Since the retinoid binding affinity of the CRABP2-RAR pathway is higher than that of the FABP5-PPARβ/δ pathway, at least a partial ATRA-mediated tumor-suppressive effect is expected in tumors with comparable FABP5 and CRABP2 expression. Here, CRABP2 is linked to neoplasm.